open/close global search bar

Related Content

Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension thumbnail image

Case Report

{{GlobalController.truncateTitle(" Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension", 65)}}
The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study thumbnail image

Original Research

{{GlobalController.truncateTitle(" The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study", 65)}}
Mechanisms of right heart disease in pulmonary hypertension (2017 Grover Conference Series) thumbnail image

Review

{{GlobalController.truncateTitle("Mechanisms of right heart disease in pulmonary hypertension (2017 Grover Conference Series)", 65)}}
Lewis Rubin - Current Guidelines thumbnail image

Conference talk

14 January 2016

{{GlobalController.truncateTitle("Lewis Rubin - Current Guidelines", 65)}}
Why Asia Offers Good Opportunities for Clinical Trials - Dr. Kevin Laliberte thumbnail image

Conference talk

15 January 2015

{{GlobalController.truncateTitle("Why Asia Offers Good Opportunities for Clinical Trials - Dr. Kevin Laliberte", 65)}}

Add to reading list

Please enter a list name.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg